Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

445
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
445
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

220
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
220
Managing Impressions01:19

Managing Impressions

178
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
178
Management of Insomnia01:19

Management of Insomnia

683
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
683
Angina IV: Management01:26

Angina IV: Management

307
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
307
Angina V: Nursing Management01:20

Angina V: Nursing Management

355
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
355

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics and clinical course of younger patients with asymptomatic monoclonal gammopathies.

British journal of haematology·2026
Same author

Risk Assessment for Venous Thrombosis in Lymphoma and Emerging Biomarkers.

International journal of molecular sciences·2026
Same author

The prognostic value of red blood cell distribution width in AL amyloidosis.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2026
Same author

Real-World Outcomes of Mycosis Fungoides and Site-Specific Nodal Involvement: A Registry-Based Study of 25 467 Patients.

American journal of hematology·2026
Same author

Diagnostic and therapeutic challenges in rare hematologic entities: monoclonal gammopathy of thrombotic and bleeding significance.

Haematologica·2026
Same author

Enhanced dynamic risk stratification of smoldering multiple myeloma.

Nature medicine·2026

Related Experiment Video

Updated: Feb 11, 2026

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

25.1K

How We Manage Patients with Plasmacytomas.

Despina Fotiou1, Meletios A Dimopoulos1, Efstathios Kastritis2

  • 1Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Current Hematologic Malignancy Reports
|April 19, 2018
PubMed
Summary

This review covers solitary plasmacytomas (SP) and their management within multiple myeloma (MM). Advanced imaging aids diagnosis, while radiotherapy is key for SP, with systemic therapy for relapse.

Keywords:
Bone diseaseExtramedullaryPlasma cellsSolitary lesionTumor

More Related Videos

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.7K

Related Experiment Videos

Last Updated: Feb 11, 2026

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

25.1K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.7K

Area of Science:

  • Hematology
  • Oncology
  • Radiology

Background:

  • Plasmacytomas, including solitary plasmacytomas (SP) and those within multiple myeloma (MM), require precise diagnostic and therapeutic strategies.
  • Understanding the distinct biological characteristics of extramedullary clonal plasma cells is crucial for patient outcomes.

Purpose of the Study:

  • To review the diagnostic approach for plasmacytomas.
  • To outline current treatment options for solitary plasmacytomas and related conditions.
  • To discuss future directions in managing plasmacytomas and multiple myeloma.

Main Methods:

  • Review of advanced imaging techniques (e.g., whole-body MRI, PET/CT) for diagnosing solitary plasmacytomas.
  • Evaluation of prognostic factors and diagnostic tools like flow cytometry for risk stratification.
  • Analysis of treatment outcomes for radiotherapy and systemic therapies.

Main Results:

  • Advanced imaging is vital to exclude disseminated disease in solitary plasmacytomas.
  • Local radiotherapy is effective for solitary plasmacytomas, but systemic therapy is needed for relapsed disease.
  • Extramedullary plasmacytomas in MM indicate ultra-high risk and poor prognosis.

Conclusions:

  • A revised definition of solitary plasmacytoma is needed to guide therapy and follow-up.
  • Further research is required to optimize treatment for patients with paraskeletal or extramedullary disease in MM.